Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 62969
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
62969
Date of registration
09.01.2014
Company name
GlaxoSmithKline AG
Revision date
Valid until
Indication
Date of market entry
Index Therapeuticus (BSV)
03.04.30.
Revocation Date
Index Therapeuticus (Swissmedic)
03.04.30.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Relvar Ellipta 92/22 mcg
Einzeldosiertes Pulver zur Inhalation
Einzeldosiertes Pulver zur Inhalation (Fluticasoni Furoas 92 µg, Vilanterolum 22 µg)
R03AK10
CI
02
Relvar Ellipta 184/22 mcg
Einzeldosiertes Pulver zur Inhalation
Einzeldosiertes Pulver zur Inhalation (Fluticasoni Furoas 184 µg, Vilanterolum 22 µg)
R03AK10
CI
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
